Navigation Links
Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie
Date:9/5/2007

s that meet critical health challenges for which there are few other treatment options. The company's pipeline includes promising early and late-stage drug candidates with unique formulations and mechanisms of action that address the needs of seriously ill patients, such as at-home chemotherapy and new treatment regimens for refractory disease. For more information, please visit our website at http://www.spectrumpharm.com.

Forward-looking statement -- This press release may contain forward- looking statements regarding future events and the future performance of Spectrum Pharmaceuticals that involve risks and uncertainties that could cause actual results to differ materially. These statements include but are not limited to statements that relate to our business and its future, Spectrum's ability to identify, acquire, develop and commercialize its portfolio of drug candidates, the Company's promising pipeline, that pivotal trials are expected to commence before year end or soon thereafter, the safety and efficacy of ozarelix, that we continue to believe that ozarelix could help serve the large unmet medical need for more effective BPH treatments and any statements that relate to the intent, belief, plans or expectations of Spectrum or its management, or that are not a statement of historical fact. Risks that could cause actual results to differ include the possibility that our existing and new drug candidates, may not prove safe or effective, the possibility that our existing and new drug candidates may not receive approval from the FDA, and other regulatory agencies in a timely manner or at all, the possibility that our existing and new drug candidates, if approved, may not be more effective, safer or more cost efficient than competing drugs, the possibility that our efforts to acquire or in-license and develop additional drug candidates may fail, our lack of revenues, our limited marketing experience, o
'/>"/>

SOURCE Spectrum Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. AEterna Zentaris Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
2. Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at Annual Meeting of American Urological Association
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013 Hurel Corporation ("Hurel"), a ... cell-based assay platforms, today announced the appointment of ... the Company,s Board of Directors. Dr. MacDonald is the ... Schering-Plough Research Institute ("SPRI"), which was the pharmaceutical development ... Merck & Co. in 2009. Over a ...
(Date:5/21/2013)... BioElectronics Corp. (PINKSHEETS: BIEL), the maker ... that CEO, Andrew J. Whelan ... Advisory Committee, Orthopedic and Rehabilitation Panel compelling arguments ... counter sales. "It,s been 37 years ... schema," Whelan said.  "While the old classification of ...
(Date:5/21/2013)...   Accuray Incorporated (Nasdaq: ... results involving hundreds of prostate cancer patients treated ... widely used form of prostate stereotactic body radiation ... a median of 5 years, and many to ... of patients with low-risk and 90.7% of patients ...
Breaking Medicine Technology:Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3
(Date:5/21/2013)... LEAWOOD, Kan. Primary care practice transformation on ... health care reform efforts aimed at achieving better ... Amid emerging evidence that transformation toward the patient-centered ... today,s health care environment, the U.S. Department of ... and Quality funded 14 studies to learn more ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Mecklenburg EMS ... will hold a free Community Wellness Fair to educate ... The fair will be held on Wednesday, May 22, 2013 ... City YMCA (8100 Old Mallard Creek Road, Charlotte, NC ... Heart Association and the Mecklenburg County Department of ...
(Date:5/21/2013)... Orsiro stent, which is a novel stent platform ... to the Xience Prime everolimus-eluting stent for the ... at nine months in the results of an ... The BIOFLOW-II substudy used intravascular ultrasound (IVUS) and ... hyperplasia and stent apposition at nine months after ...
(Date:5/21/2013)... Boca Raton, Fla. (PRWEB) May 21, 2013 ... TV program distributed on cable networks and cable channels ... of new episodes on its YouTube channel. The producers ... profiles of companies in the shipping industry, the manufacturing ... program highlights pioneering medical facilities and medical practitioners in ...
(Date:5/21/2013)... 21, 2013 MedMar Healing Center ... benefit Second Harvest Food Bank. Twenty-eight businesses, including MedMar Healing ... the food drive. The goal is to raise food to ... problems facing their families in recent years. , “We ... help those in need,” explains Douglas Chloupek of MedMar Healing ...
Breaking Medicine News(10 mins):Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 2Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 3Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 4Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 5Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 6Health News:Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives 2Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2Health News:San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank 2
... Covance Inc. (NYSE: CVD ) today announced that ... on Wednesday, March 11, 2009 at 1:30 p.m. (ET). ... www.covance.com . In order to register and download ... headquarters in Princeton, New Jersey, is one of the world,s ...
... California, San Diego School of Medicine have identified a key ... to divide and replicate themselves. The rapid generation of ... body,s antibody defense mechanism. However, when B cells grow ... multiple myeloma or, when they grow to attack the wrong ...
... Selects Desktop and Production Messaging Solutions for Significant Savings, ... ... Norcross, GA (PRWEB) March 8, ... (NasdaqCM: ESIC)(easylink.com), a global provider of comprehensive messaging services, ...
... Jacqueline Foreman is pleased to be interviewing Dr. Barry Sears ... Talk Radio on Blogtalkradio at www.blogtalkradio.com/yourmentalhealth on Tuesday, ... Listeners are encouraged to call in with their questions at ... join our live members only chat session. If you miss ...
... as family situations change, study finds , , SATURDAY, March ... spoiling grandchildren, but a new study says they might ... and behavior. , Spending time with grandma ... divorced/separated or stepfamily households, according to the report, published ...
... Church of Scientology,s Freedom Magazine article on psychiatric screening was ... , ... Los Angeles, Ca (PRWEB) March 6, 2009 ... has been recognized by the Religion Communicators Council (RCC) with the ...
Cached Medicine News:Health News:Protein helps immune cells to divide and conquer 2Health News:Email Fax Provider, EasyLink Services, Announces Prominent Bio-Pharma Signing 2Health News:Email Fax Provider, EasyLink Services, Announces Prominent Bio-Pharma Signing 3Health News:Zone Diet Creator Dr. Barry Sears to Talk About Latest Book Toxic Fat: When Good Fat Turns Bad 2Health News:Zone Diet Creator Dr. Barry Sears to Talk About Latest Book Toxic Fat: When Good Fat Turns Bad 3Health News:In Tough Times, Kids May Find Solace With Grandparents 2Health News:Scientology Magazine Earns Religion Communicators Council Award 2
... Synergy T-EP - EMG/EP monitoring systems range ... T2EP, T5EP and T10EP systems. These 2, ... in collaboration with leading practitioners, for ease ... of clinical testing. Synergy T-EP harnesses PC ...
Neuropack Sigma MEB-5500 series evoked potential measuring system is a compact, portable, all-in-one unit....
... MYOHANDY family are probably the most ... SystemPLUS line. Based on last generation ... the ISA 100x EP series with ... EP) , 4 channels (ISA 1004, ...
Sierra II power & efficiency plus. Sierra II report generator with automatic sentence generation creates the one-minute report. Complete 2/4 channel EMG/NCV/EP....
Medicine Products: